Skip to main content
CG Invites Co., Ltd. logo

CG Invites Co., Ltd. — Investor Relations & Filings

Ticker · 083790 ISIN · KR7083790006 KO Manufacturing
Filings indexed 450 across all filing types
Latest filing 2021-05-28 Director's Dealing
Country KR South Korea
Listing KO 083790

About CG Invites Co., Ltd.

https://cginvites.com/en

CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by company directors and major shareholders to disclose their personal share transactions (insider trading). Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2021-05-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and Korea Exchange. It details specific share transactions (purchases) made by an executive (CEO Cho Joong-myung) of CrystalGenomics Inc. This type of filing is a standard regulatory disclosure for insider trading/director dealings in the Korean market.
2021-05-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding changes of the company's CEO (Joong Myung Cho) and related parties, including acquisition methods like stock options and market purchases. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-05-28 Korean
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a 'Business Report' (사업보고서), which is the Korean equivalent of a 10-K. It contains detailed corporate history, capital structure changes, share issuance history, and financial data tables. Since it is a formal amendment to an annual filing, it is classified as a 10-K. FY 2020
2021-05-17 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for CrystalGenomics, Inc. covering the period from January 1, 2021, to March 31, 2021. It contains detailed financial statements, management discussion, and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-17 Korean
불성실공시법인지정(공시불이행)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory announcement regarding the designation of CrystalGenomics as an 'unfaithful disclosure corporation' (불성실공시법인) due to a failure to disclose litigation in a timely manner. This is a regulatory notice concerning compliance and penalties, which does not fit into specific categories like financial reports or shareholder meetings. Therefore, it is classified as a Regulatory Filing (RNS).
2021-04-29 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.